Mustea A - Search Results

1

Vascular endothelial growth factor gene polymorphisms in ovarian cancer.

Polterauer S, Grimm C, Mustea A, Concin N, Tanner B, Thiel F, Heinze G, Reinthaller A, Zeillinger R, Hefler LA. Polterauer S, et al. Among authors: mustea a. Gynecol Oncol. 2007 May;105(2):385-9. doi: 10.1016/j.ygyno.2006.12.021. Epub 2007 Feb 6. Gynecol Oncol. 2007. PMID: 17289129

2

Interleukin-1 receptor antagonist gene polymorphism in epithelial ovarian cancer.

Sehouli J, Mustea A, Koensgen D, Lichtenegger W. Sehouli J, et al. Among authors: mustea a. Cancer Epidemiol Biomarkers Prev. 2003 Nov;12(11 Pt 1):1205-8. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 14652282

3

Expression of IL-10 in patients with ovarian carcinoma.

Mustea A, Könsgen D, Braicu EI, Pirvulescu C, Sun P, Sofroni D, Lichtenegger W, Sehouli J. Mustea A, et al. Anticancer Res. 2006 Mar-Apr;26(2C):1715-8. Anticancer Res. 2006. PMID: 16617566 Free article.

4

Polymorphism of IL-1alpha, IL-1beta and IL-10 in patients with advanced ovarian cancer: results of a prospective study with 147 patients.

Ioana Braicu E, Mustea A, Toliat MR, Pirvulescu C, Könsgen D, Sun P, Nürnberg P, Lichtenegger W, Sehouli J. Ioana Braicu E, et al. Among authors: mustea a. Gynecol Oncol. 2007 Mar;104(3):680-5. doi: 10.1016/j.ygyno.2006.10.014. Epub 2006 Dec 1. Gynecol Oncol. 2007. PMID: 17141301

5

Vascular endothelial growth factor gene polymorphisms are associated with prognosis in ovarian cancer.

Hefler LA, Mustea A, Könsgen D, Concin N, Tanner B, Strick R, Heinze G, Grimm C, Schuster E, Tempfer C, Reinthaller A, Zeillinger R. Hefler LA, et al. Among authors: mustea a. Clin Cancer Res. 2007 Feb 1;13(3):898-901. doi: 10.1158/1078-0432.CCR-06-1008. Clin Cancer Res. 2007. PMID: 17289883

6

Epidermal growth factor receptor (EGFR) mutation does not correlate with platinum resistance in ovarian carcinoma. Results of a prospective pilot study.

Mustea A, Sehouli J, Fabjani G, Koensgen D, Möbus V, Braicu EI, Pirvulescu C, Thomas A, Tong D, Zeillinger R. Mustea A, et al. Anticancer Res. 2007 May-Jun;27(3B):1527-30. Anticancer Res. 2007. PMID: 17595771 Free article.

7

The -463G/A polymorphism in myeloperoxidase gene and cervical cancer.

Mustea A, Heinze G, Sehouli J, Koensgen D, Wolf A, Gutu L, Sofroni D, Pirvulescu C, Braicu EI, Schuster E, Zeillinger R, Tong D. Mustea A, et al. Anticancer Res. 2007 May-Jun;27(3B):1531-5. Anticancer Res. 2007. PMID: 17595772 Free article.

8

Expression analysis and RNA localization of PAI-RBP1 (SERBP1) in epithelial ovarian cancer: association with tumor progression.

Koensgen D, Mustea A, Klaman I, Sun P, Zafrakas M, Lichtenegger W, Denkert C, Dahl E, Sehouli J. Koensgen D, et al. Among authors: mustea a. Gynecol Oncol. 2007 Nov;107(2):266-73. doi: 10.1016/j.ygyno.2007.06.023. Epub 2007 Aug 14. Gynecol Oncol. 2007. PMID: 17698176

9

Serum C-reactive protein as independent prognostic variable in patients with ovarian cancer.

Hefler LA, Concin N, Hofstetter G, Marth C, Mustea A, Sehouli J, Zeillinger R, Leipold H, Lass H, Grimm C, Tempfer CB, Reinthaller A. Hefler LA, et al. Among authors: mustea a. Clin Cancer Res. 2008 Feb 1;14(3):710-4. doi: 10.1158/1078-0432.CCR-07-1044. Clin Cancer Res. 2008. PMID: 18245530

10

KRAS mutation analysis in ovarian samples using a high sensitivity biochip assay.

Auner V, Kriegshäuser G, Tong D, Horvat R, Reinthaller A, Mustea A, Zeillinger R. Auner V, et al. Among authors: mustea a. BMC Cancer. 2009 Apr 9;9:111. doi: 10.1186/1471-2407-9-111. BMC Cancer. 2009. PMID: 19358724 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

200 results

Search Page

Filters